IP Library › Granted Patent US 12,220,381
Granted Patent B2
US 12,220,381 · App. 17/509,691 · Granted Feb 11, 2025

Drug security systems and methods

Inventors: Michael A. Lafauci (Center Moriches, NY); Jeffrey R. Wahl (Beachwood, OH); Andrew M. Brown (Hackensack, NJ); Jonathan Pinsky (Bedford, NY)
Assignee: MIDAS Healthcare Solutions, Inc.
A61J1/1437A61J1/1406A61J1/16A61J1/201A61J1/2096A61J2205/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,220,381
App. No.
17/509,691
Granted
Feb 11, 2025
Kind
B2
Abstract

The present disclosure provides an injectable medication security device. The device may comprise a recess on a first portion of the device. The recess may be configured to receive and couple to a neck portion of a vial containing the injectable medication. The device may comprise an opening on a second portion of the device, to permit access to a penetrable cover of the vial. The device may comprise at least one aperture configured to control access to the opening. The device may comprise a depressible switch. The depressible switch may be configured to cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, thereby permitting the medication to be drawn from the vial. The depressible switch may be configured to cause the at least one aperture to lock and close the opening when the depressible switch is released.

Claims (30)

1. An injectable medication security device, comprising:

a recess provided on a first portion of the device, wherein the recess is configured to receive and couple to a neck portion of a vial containing the injectable medication;

an opening provided on a second portion of the device, wherein the opening permits access to a penetrable cover located near the neck portion of the vial;

at least one aperture located at the opening and configured to control access to the opening; and

a depressible switch operatively coupled to the at least one aperture, wherein the depressible switch is configured to (1) cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, thereby permitting the medication to be drawn from the vial, and (2) cause the at least one aperture to lock and close the opening when the depressible switch is released, thereby preventing further access to any residual medication within the vial.

2. The injectable medication security device of claim 1 , wherein the at least one aperture comprises a scannable visual code that is revealed when the depressible switch is released.

3. The injectable medication security device of claim 1 , wherein the at least one aperture is closed prior to withdrawing the medication from the vial; and wherein the depressible switch is configured to (1) cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, and (2) cause the at least one aperture to lock and close the opening when the depressible switch is released.

4. The injectable medication security device of claim 2 , wherein the scannable visual code is segmented into a plurality of partial codes.

5. The injectable medication security device of claim 4 , wherein the plurality of partial codes are disposed on a plurality of movable segments of the at least one aperture.

6. The injectable medication security device of claim 5 , wherein the plurality of partial codes are reconstructed to form the scannable visual code when the at least one aperture is closed.

7. The injectable medication security device of claim 1 , further comprising a cap removal device configured to remove a cap of the vial to permit access to the penetrable cover of the vial.

8. The injectable medication security device of claim 1 , further comprising a removable safety device configured to prevent movement of the depressible switch.

9. The injectable medication security device of claim 1 , further comprising a sensor configured to detect a frequency of insertion of a needle (1) through the penetrable cover or (2) into the vial.

10. A method of monitoring a use of a vial containing an injectable medication, comprising:

(a) providing an injectable medication security device, comprising:

a recess provided on a first portion of the device, wherein the recess is configured to receive and couple to a neck portion of the vial;

an opening provided on a second portion of the device, wherein the opening permits access to a penetrable cover located near the neck portion of the vial;

at least one aperture located at the opening and configured to control access to the opening; and

a depressible switch operatively coupled to the at least one aperture, wherein the depressible switch is configured to (1) cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, thereby permitting the medication to be drawn from the vial, and (2) cause the at least one aperture to lock and close the opening when the depressible switch is released, thereby preventing further access to any residual medication within the vial;

(b) coupling the recess of the injectable medication security device to the neck portion of the vial;

(c) depressing the depressible switch to direct the at least one aperture to open; and

(d) releasing the depressible switch to direct the at least one aperture to close.

11. The method of claim 10 , wherein the at least one aperture comprises a scannable visual code that is revealed when the depressible switch is released, and wherein the method further comprises, subsequent to (d), scanning the scannable visual code.

12. The method of claim 10 , wherein the at least one aperture is closed prior to withdrawing the medication from the vial; and wherein the depressible switch is configured to (1) cause the at least one aperture to open and provide access to the opening when the depressible switch is depressed, and (2) cause the at least one aperture to lock and close the opening when the depressible switch is released.

13. The method of claim 11 , wherein the scannable visual code is segmented into a plurality of partial codes.

14. The method of claim 13 , wherein the plurality of partial codes are disposed on a plurality of movable segments of the at least one aperture.

15. The method of claim 14 , further comprising reconstructing the plurality of partial codes into the scannable visual code.

16. The method of claim 10 , further comprising removing, with aid of a cap removal device, a cap of the vial to permit access to the penetrable cover of the vial.

17. The method of claim 10 , further comprising removing a removable safety device, wherein the removable safety device is configured to prevent movement of the depressible switch when coupled to the injectable medication security device.

18. The method of claim 10 , further comprising detecting, with aid of a sensor, a frequency of insertion of a needle (1) through the penetrable cover or (2) into the vial.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2022
From: LAFAUCI, MICHAEL A.; WAHL, JEFFREY R.; BROWN, ANDREW M.; PINSKY, JONATHAN
To: MIDAS HEALTHCARE SOLUTIONS, INC.
Reel/Frame 059532/0803 →
Continuity (4)
Continuation PCTUS2020029588 · Apr 23, 2020
Provisional Application 62873617 · Jul 12, 2019
Provisional Application 62839361 · Apr 26, 2019
Related Publication 20220142862A1 · May 12, 2022
References Cited (45)
US 3711683A · Hamisch · 1973 [cited by applicant]
US 5230429A · Etheredge, III · 1993 [cited by applicant]
US 5384947A · Kildal et al. · 1995 [cited by applicant]
US 5852590A · de la Huerga · 1998 [cited by examiner]
US 6259654B1 · de la Huerga · 2001 [cited by examiner]
US 8251290B1 · Bushman et al. · 2012 [cited by applicant]
US 10628647B1 · Rossier et al. · 2020 [cited by applicant]
US 20050285377A1 · Meyendorff et al. · 2005 [cited by applicant]
US 20070145140A1 · Yoshimura et al. · 2007 [cited by applicant]
US 20110186623A1 · Truesdale · 2011 [cited by applicant]
US 20120046635A1 · Hedgepeth · 2012 [cited by examiner]
US 20130031623A1 · Sanders · 2013 [cited by applicant]
US 20130126601A1 · Lee · 2013 [cited by applicant]
US 20130312373A1 · Bogle et al. · 2013 [cited by applicant]
US 20140196136A1 · Hill et al. · 2014 [cited by applicant]
US 20140284382A1 · Park · 2014 [cited by applicant]
US 20150105745A1 · Banik · 2015 [cited by examiner]
US 20150224028A1 · Carrel · 2015 [cited by examiner]
US 20150367230A1 · Bradford et al. · 2015 [cited by applicant]
US 20170046548A1 · Kamijo et al. · 2017 [cited by applicant]
US 20170068785A1 · Experton et al. · 2017 [cited by applicant]
US 20170189270A1 · Nazzaro et al. · 2017 [cited by applicant]
US 20170287184A1 · Pettersson · 2017 [cited by applicant]
US 20170351909A1 · Kaehler · 2017 [cited by applicant]
US 20190262230A1 · Bentkovski · 2019 [cited by examiner]
US 20220215216A1 · Wahl et al. · 2022 [cited by applicant]
DE 19807232C1 · 1999 [cited by applicant]
DE 102013011238A1 · 2015 [cited by applicant]
EP 0275578A1 · 1988 [cited by applicant]
EP 2913086A2 · 2015 [cited by applicant]
EP 3410340A1 · 2018 [cited by applicant]
JP 2009183390A · 2009 [cited by applicant]
WO WO2020172471A1 · 2020 [cited by applicant]
WO WO2020206154A1 · 2020 [cited by applicant]
WO WO2020219724A1 · 2020 [cited by applicant]
EP20795518.8 Extended European Search Report dated Nov. 30, 2022. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2020/029588 issued Jul. 14, 2020. [cited by applicant]
EP20759289.0 Extended European Search Report dated Sep. 29, 2022. [cited by applicant]
PCT/US2020/019122 International Search Report and Written Opinion dated Jul. 16, 2020. [cited by applicant]
Ruth et al. Secure Multi-User Content Sharing for Augmented Reality Applications. Proceedings of the 28th USENIX Security Symposium, pp. 141-158, Santa Clara, CA, USA (Aug. 14-16, 2019). Available at URL: https://www.us… [cited by applicant]
U.S. Appl. No. 17/407,601 Office Action dated Aug. 3, 2023. [cited by applicant]
Co-pending U.S. Appl. No. 18/768,622, inventors Wahl; Jeffrey R. et al., filed Jul. 10, 2024. [cited by applicant]
U.S. Appl. No. 17/407,601 Notice of Allowance dated Jun. 3, 2024. [cited by applicant]
Tarng, Wernhaur, et al., Development of a Virtual Butterfly Ecological System Based on Augmented Reality and Mobile Learning Technologies. Virtual Reality 19:253-266 (2015). [cited by applicant]
U.S. Appl. No. 17/407,601 Notice of Allowance dated Apr. 19, 2024. [cited by applicant]